Ortho Biotech’s combination of doxorubicin HCl liposome injection (Doxil) plus bortezomib (Velcade) has been approved to treat patients with multiple myeloma who have not previously received Velcade and who have received at least one previous therapy. In an international phase 3 trial, the combination, compared with bortezomib alone, significantly extended the median time to disease [...]
Boston Scientific Corp. has completed enrollment of more than 23,000 patients in the European and Intercontinental phases (2 and 3) of its Taxus Olympia registry. The registry is designed to evaluate the safety and performance of its second-generation drug-eluting coronary stent, Taxus Liberte, in a real-world setting. Olympia is the world’s largest drug-eluting stent registry. [...]
An FDA advisory committee has voted to include children younger than five years of age to be eligible to receive Med-Immune’s live intranasal influenza virus vaccine (FluMist). FluMist is approved for healthy children and adolescents 5 to 17 years of age and for healthy adults 18 to 49 years of age. The data demonstrated the [...]
A topical liquid, Evicel Fibrin Sealant (Omrix/Ethicon), has been approved for use in vascular surgery. Evicel helps control oozing from small blood vessels. Derived from pooled human plasma, the sealant consists of a fibrinogen concentrate and thrombin, both of which promote clotting and help reduce the risk of viral transmission in manufacturing. alendronate 70 mg [...]
